Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-27T12:02:57.787Z Has data issue: false hasContentIssue false
  • English
  • Français

Nasal Carriage of Staphylococcus aureus Among Patients Receiving Allergen-Injection Immunotherapy: Associated Factors and Quantitative Nasal Cultures

Published online by Cambridge University Press:  02 January 2015

Stefano Bassetti ,
Donnie P. Dunagan ,
Ralph B. D'Agostino Jr  and
Robert J. Sherertz
Stefano Bassetti
Affiliation:
Section on Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, North-Carolina
Donnie P. Dunagan
Affiliation:
Section on Pulmonary/Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, North-Carolina
Ralph B. D'Agostino Jr
Affiliation:
Section on Biostatistics, Wake Forest University School of Medicine, Winston-Salem, North-Carolina
Robert J. Sherertz*
Affiliation:
Section on Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, North-Carolina
*
Section on Infectious Diseases, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1042
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To compare the prevalence of nasal Staphylococcus aureus carriage among outpatients receiving allergen-injection immunotherapy with the prevalence among healthy controls and to determine predictors of nasal S aureus carriage.

Design:

Survey.

Setting:

Allergy clinic of a university hospital.

Participants:

A volunteer sample consisting of 45 outpatients undergoing desensitization therapy and 84 first- and second-year medical students.

Results:

The nasal S aureus carriage rate was significantly higher among patients (46.7%) than among students (26.2%; P=.019). In a multivariate model adjusted for age and gender, the presence of atopic dermatitis or eczema was the only independent predictor of nasal S aureus carriage (odds ratio [OR], 4.4; 95% confidence interval [CI95], 1.2-16.0; P=.02). The only other participant characteristic associated with nasal S aureus carriage was immunotherapy with allergen injections (OR, 1.98; CI95, 0.7-6.0), but this association did not reach statistical significance (P=.23). The probability of nasal S aureus carriage was 88.9% for patients receiving allergen injections and having atopic dermatitis or eczema, and 36.1% for patients receiving allergen injections without atopic dermatitis or eczema.

Conclusions:

Patients undergoing desensitization have a higher nasal carriage rate of S aureus. However, factors other than the regular use of needles, and in particular abnormalities related to the atopic constitution of these patients, may predispose this population for S aureus carriage.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 12 , December 2001 , pp. 741 - 745
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1996, issued May 1996. A report from the NNIS System. Am J Infect Control 1996;24:380–388.Google Scholar
2. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. Am J Infect Control 1999;27:520–532.Google Scholar
3. Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.CrossRefGoogle ScholarPubMed
4. Kirkland, KB, Briggs, JP, Trivette, SL, Wilkinson, WE, Sexton, DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725–730.Google Scholar
5. Herold, BC, Immergluck, LC, Maranan, MC, Lauderdale, DS, Gaskin, RE, Boyle-Vavra, S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593–598.Google Scholar
6. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin—Illinois, 1999. MMWR 2000;48:1165–1167.Google Scholar
7. Kluytmans, J, van Belkum, A, Verbrugh, H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505–520.CrossRefGoogle ScholarPubMed
8. Perl, TM, Golub, JE. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother 1998;32(suppl):S7–S16.CrossRefGoogle ScholarPubMed
9. Winkler, J, Block, C, Leibovici, L, Faktor, J, Pitlik, SD. Nasal carriage of Staphylococcus aureus: correlation with hormonal status in women. J Infect Dis 1990;162:1400–1402.CrossRefGoogle ScholarPubMed
10. Gittelman, PD, Jacobs, JB, Lebowitz, AS, Tierno, PM Jr. Staphylococcus aureus nasal carriage in patients with rhinosinusitis. Laryngoscope 1991;101:733–737.CrossRefGoogle ScholarPubMed
11. Aly, R, Maibach, HI, Shinefield, HR. Microbial flora of atopic dermatitis. Arch Dermatol 1977;113:780–782.CrossRefGoogle ScholarPubMed
12. Kirmani, N, Tuazon, CU, Ailing, D. Carriage rate of Staphylococcus aureus among patients receiving allergy injections. Ann Allergy 1980;45:235–237.Google ScholarPubMed
13. Klein, PA, Greene, WH, Fuhrer, J, Clark, RAF. Prevalence of methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Arch Dermatol 1997;133:1463–1465.CrossRefGoogle ScholarPubMed
14. Namura, S, Nishijima, S, Higashida, T, Asada, Y. Staphylococcus aureus isolated from nostrils anteriors and subungual spaces of the hand: comparative study of medical staff, patients and normal controls. J Dermatol 1995;22:175–180.CrossRefGoogle ScholarPubMed
15. Bibel, DJ, Aly, R, Shinefield, HR, Maibach, HI, Strauss, WG. Importance of the keratinized epithelial cell in bacterial adherence. J Invest Dermatol 1982;79:250–253.CrossRefGoogle ScholarPubMed
16. Holm, AF, Fokkens, WJ, Godthelp, T, Mulder, PG, Vroom, TM, Rijntjes, E. Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995;50:204–209.CrossRefGoogle Scholar
17. Yuta, A, Ali, M, Sabol, M, Gaumond, E, Baraniuk, JN. Mucoglycoprotein hypersecretion in allergic rhinitis and cystic fibrosis. Am J Physiol 1997;273(6 pt 1):L1203–L1207.Google Scholar
18. Shuter, J, Hatcher, VB, Lowy, FD. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996;64:310–318.Google Scholar
19. Shiomori, T, Yoshida, S, Miyamoto, H, Makishima, K. Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis. J Allergy Clin Immunol 2000;105:449–454.CrossRefGoogle ScholarPubMed